Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary”

27,620 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27,620 results

Not applicableStudy completedNCT03287830
What this trial is testing

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine

Who this might be right for
InfluenzaVaccination
Columbia University 2,105
Testing effectiveness (Phase 2)Ended earlyNCT04786600
What this trial is testing

A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial

Who this might be right for
Metastatic Colorectal Cancer
University of Florida 6
Not applicableLooking for participantsNCT06643000
What this trial is testing

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal MetastasisEGFR Gene Mutation
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03866967
What this trial is testing

Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 130
Early research (Phase 1)Study completedNCT05400265
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

Who this might be right for
Adult Solid Tumor
Shanghai Henlius Biotech 9
Testing effectiveness (Phase 2)Looking for participantsNCT05584267
What this trial is testing

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 140
Testing effectiveness (Phase 2)Looking for participantsNCT06242067
What this trial is testing

Second-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Hospital of Shandong University 50
Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Large-scale testing (Phase 3)Looking for participantsNCT06276465
What this trial is testing

Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging

Who this might be right for
Prostatic Cancer, Castration-Resistant
UNICANCER 336
Not applicableStudy completedNCT02600065
What this trial is testing

Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy

Who this might be right for
Cytomegalovirus Infections
University of Erlangen-Nürnberg Medical School 350
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Very early researchNot Yet RecruitingNCT06676800
What this trial is testing

Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis

Who this might be right for
Tuberculosis-related Obstructive Pulmonary Disease
Fourth Affiliated Hospital of Xinjiang Medical University 74
Early research (Phase 1)Study completedNCT00243100
What this trial is testing

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT01075100
What this trial is testing

Ixabepilone + Carboplatin Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
US Oncology Research 103
Large-scale testing (Phase 3)Ended earlyNCT01006252
What this trial is testing

Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Who this might be right for
Melanoma
Eli Lilly and Company 336
Large-scale testing (Phase 3)Study completedNCT00026338
What this trial is testing

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NCIC Clinical Trials Group 569
Post-approval studies (Phase 4)Study completedNCT01064947
What this trial is testing

Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis

Who this might be right for
Atopic DermatitisSecondary Infection
Derm Research, PLLC 29
Not applicableActive Not RecruitingNCT06083038
What this trial is testing

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

Who this might be right for
Metastatic Breast Cancer
HealthPartners Institute 15
Testing effectiveness (Phase 2)Looking for participantsNCT07232849
What this trial is testing

A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301
What this trial is testing

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Who this might be right for
Small Cell Lung Cancer Extensive StageResistance to Immunotherapy
First Affiliated Hospital of Wannan Medical College 25
Load More Results